WATCH: In this HealthTree Foundation interview, Ontada's Lisa Herms, PhD, discusses a research study examining real-world patient characteristics and outcomes in diffuse large B-cell lymphoma (DLBCL) before and after the approval of CAR-T therapies. https://lnkd.in/gxukCF88 #DLBCL #Lymphoma #RWD #ASH24
